Skip to main content
. Author manuscript; available in PMC: 2016 Aug 22.
Published in final edited form as: Cancer. 2010 Aug 15;116(16):3852–3861. doi: 10.1002/cncr.25123

Figure 1.

Figure 1

This is a Consolidated Standards of Reporting Trials (CONSORT) diagram for patients with chronic myeloid leukemia in blast phase. QD indicates once-daily dasatinib; BID, twice-daily dasatinib; AE, adverse event; SCT, stem cell transplantation.